Effect of deguelin on expression of nup98 in K562 cells.
- Author:
Qiu-Ling WU
1
;
Yan CHEN
;
Wei-Hua CHEN
;
Jing HE
Author Information
1. Institute of Hematology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents, Phytogenic;
pharmacology;
Cell Proliferation;
Dose-Response Relationship, Drug;
Humans;
K562 Cells;
Nuclear Pore Complex Proteins;
biosynthesis;
genetics;
RNA, Messenger;
biosynthesis;
genetics;
Rotenone;
analogs & derivatives;
pharmacology
- From:
Journal of Experimental Hematology
2007;15(1):25-28
- CountryChina
- Language:Chinese
-
Abstract:
The study was purposed to investigate the effect of deguelin on expression of nucleoporin 98 (nup98) in leukemia K562 cells. MTT assay was used to assess the effects of deguelin on cell proliferation. FCM and RT-PCR were used to analyze the changes of nup98 mRNA and protein in K562 cells after treating with deguelin. The results showed that deguelin inhibited the proliferation of K562 cells in a time- and dose-dependent manner; mean fluorescence intensity of nup98 in blank group (34.22 +/- 1.63) was significantly higher than that in control group (2.83 +/- 0.02, P < 0.01), 10 nmol/L deguelin could significantly inhibit the expression of nup98 protein; 10 nmol/L could not inhibit the expression of nup98 mRNA, 20, 40, 80, 160 nmol/L deguelin could significantly inhibit the expression of nup98 mRNA in a dose-dependant manner. It is concluded that deguelin inhibits the proliferation of K562 cell through inhibiting the expression of nup98, and may be considered as a new target for therapy of acute leukemia.
